Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Harbour BioMed and Chia Tai Tianqing announced they are entering into a strategic alliance to discover, develop and commercialize next-generation biologics.
read more
HBM and Erasmus MC, University Medical Center Rotterdam have signed a 10-year MOU to enable a range of joint research activities to develop next generation biotherapeutics.
read more
Harbour BioMed and PPD announced a strategic collaboration to develop HBM’s innovative therapeutics in the fields of oncology and immunology.
read more
Tuesday, December 29, 2020
Harbour BioMed and Utrecht University announced that they licensed to AbbVie their fully human, SARS-CoV-2 neutralizing antibody, 47D11 and program, for the prevention and treatment of COVID-19.
read more
Harlan Laboratories, Ltd., a privately held provider of general and specialty toxicology services through its Contract Research Services (CRS) business, and Fluofarma, a contract research organization specializing in high content analysis, have ...
read more
Harlan Contract Research Services and Bertin Pharma, headquartered in Montigny-le-Bretonneux, 3.France, announced a strategic partnership to offer a comprehensive package for early drug development. Under the agreement, the companies will offer a ...
read more
Thursday, August 08, 2013
Harlan Contract Research Services (CRS) Cytotest Cell Research GmbH in Rossdorf, Germany, has been named one of the first laboratories selected for inclusion in the European Union Network of Laboratories for the Validation of Alternative Methods (EU-...
read more
Thursday, August 22, 2013
A workshop to discuss ways of improving the quality of drugs entering into the preclinical stage of development will be led by Ciriaco Maraschiello, PhD, director of drug discovery and translational medicines for Harlan Contract Research Services (...
read more
Harlan Laboratories, Ltd., a privately held provider of general and specialty toxicology services through its Contract Research Services(CRS) business, is prepared to meet the global demand for development programs in novel biologics and biosimilars.
read more
Harm Reduction Therapeutics, a 501(c)(3) non-profit pharmaceutical company whose mission is to prevent opioid overdose deaths by making low-cost naloxone available to everyone, and Catalent announced the signing of a commercial supply agreement.
read more
Guadalupe, Nuevo Leon, Harmonic Nature is voluntarily recalling all 800 bottles Hand Sanitizer, 250mL, product due to the potential presence of 1-propanol.
read more
Wednesday, November 12, 2014
announces that Biocon, one of Asia’s premier biotechnology companies, has just launched INSUPen® EZ in India. The INSUPen® EZ is a second generation pen and follows on the success of Biocon’s premier insulin delivery device INSUPen®. Under the terms ...
read more
Hawkins has announced that it recently completed its acquisition of Stauber Performance Ingredients from ICV Partners II, L.P. and its other shareholders in a cash for stock transaction.
read more
HCATS and apceth Biopharma have expanded their relationship with bluebird bio with long-term development and manufacturing services agreements for clinical and commercial supply for multiple therapies.
read more
HCL Technologies Limited announced the acquisition of C3i Solutions, a multi-channel customer engagement services for the life sciences and consumer packaged goods (CPG) industries, from Merck.
read more